Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

EGX:MPCI Revenue

Memphis Pharmaceuticals & Chemical Industries had revenue of 309.36M EGP in the quarter ending March 31, 2025, with 31.76% growth. This brings the company's revenue in the last twelve months to 1.30B, up 46.92% year-over-year. In the fiscal year ending June 30, 2024, Memphis Pharmaceuticals & Chemical Industries had annual revenue of 871.91M with 31.34% growth.

• Revenue (ttm): 1.30B
• Revenue Growth: +46.92%
• P/S Ratio: 1.26
• Revenue / Employee: 9.06M
• Employees: 144
• Market Cap: 1.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	871.91M	208.07M	31.34%
Jun 30, 2023	663.83M	112.57M	20.42%
Jun 30, 2022	551.26M	33.15M	6.40%
Jun 30, 2021	518.11M	29.70M	6.08%
Jun 30, 2020	488.41M	125.34M	34.52%